Skip to main content
TipRanks
Go Ultimate75% OFF

Aarti Pharmalabs Limited (AARTIPHARM) Financial Statements

2 Followers

Aarti Pharmalabs Limited Financial Overview

Aarti Pharmalabs Limited's market cap is currently ₹92.17B. The company's EPS TTM is ₹23.51; its P/E ratio is 35.88; and it has a dividend yield of 0.34%. Aarti Pharmalabs Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 18.19B₹ 21.15B₹ 18.16B₹ 19.45B₹ 11.92B
Gross Profit₹ 9.85B₹ 9.87B₹ 3.91B₹ 4.14B₹ 3.12B
Operating Income₹ 2.98B₹ 3.77B₹ 2.81B₹ 2.80B₹ 1.65B
EBITDA₹ 3.84B₹ 4.74B₹ 3.91B₹ 3.44B₹ 1.98B
Net Income₹ 1.75B₹ 2.72B₹ 2.17B₹ 1.93B₹ 1.22B
Balance Sheet
Cash & Short-Term Investments₹ 96.16M₹ 558.57M₹ 940.33M₹ 631.11M₹ 832.73M
Total Assets₹ 34.82B₹ 29.06B₹ 25.82B₹ 22.44B₹ 20.40B
Total Debt₹ 7.54B₹ 4.13B₹ 2.85B₹ 2.15B₹ 3.41B
Net Debt₹ 7.45B₹ 4.06B₹ 2.62B₹ 2.03B₹ 2.58B
Total Liabilities₹ 13.57B₹ 9.16B₹ 8.25B₹ 6.86B₹ 6.53B
Stockholders' Equity₹ 21.25B₹ 19.90B₹ 17.57B₹ 15.58B₹ 13.86B
Cash Flow
Free Cash Flow₹ -1.86B₹ -704.76M₹ 175.69M₹ 1.30B₹ -1.85B
Operating Cash Flow₹ 2.62B₹ 3.32B₹ 2.16B₹ 2.50B₹ -437.04M
Investing Cash Flow₹ -4.31B₹ -4.14B₹ -2.15B₹ -1.58B₹ -1.39B
Financing Cash Flow₹ 1.71B₹ 654.35M₹ 97.23M₹ -1.63B₹ 2.60B

Currency in INR

Aarti Pharmalabs Limited Earnings and Revenue History

-12B012B24B9 %10.5 %12 %13.5 %EarningsProfit Margin2020202120222023202420252026RevenueEarningsProfit Margin

Aarti Pharmalabs Limited Liabilities to Assets

015B30B45B0 %15 %30 %45 %LiabilitiesLiabilities to Assets2020202120222023202420252026AssetsLiabilitiesLiabilities to Assets

Aarti Pharmalabs Limited Cash Flow

-6B-4B-2B02B4B2020202120222023202420252026OperatingInvestingFinancing

Aarti Pharmalabs Limited Forecast EPS vs Actual EPS

246810Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27EPS EstimateBeatMiss